DrugId:  1
1. Name:  Tetrahydrocannabivarin
2. Groups:  Investigational
3. Description:  Tetrahydrocannabivarin has been investigated for the treatment of Dyslipidemias and Diabetes Mellitus, Type 2.
4. Indication:  Not Available
